June 25 (Reuters) - Precision BioSciences Inc DTIL.O:
PRECISION BIOSCIENCES RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR PBGENE-DMD FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
Source text: ID:nBwc1Vhyla
Further company coverage: DTIL.O
((Reuters.Briefs@thomsonreuters.com;))